Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Thrombosis Research|March 1, 1995
Platelet aggregation monitored in a 96 well microplate reader is useful for evaluation of platelet agonists and antagonistsB Bednar, C Condra, R J Gould, et al.
Water Research|June 23, 2007
Performance of porous inorganic membranes in non-osmotic desalinationM C Duke, S Mee, J C Diniz da Costa
The Journal of Biological Chemistry|August 28, 1999
The platelet cytoskeleton regulates the affinity of the integrin alpha(IIb)beta(3) for fibrinogenJ S Bennett, S Zigmond, G Vilaire, et al.
Molecular Pharmacology|August 1, 1997
Arginine-glycine-aspartic acid mimics can identify a transitional activation state of recombinant alphaIIb beta3 in human embryonic kidney 293 cellsD G Abraham, E M Nutt, R A Bednar, et al.
Cytometry|May 1, 1997
Flow cytometric measurement of kinetic and equilibrium binding parameters of arginine-glycine-aspartic acid ligands in binding to glycoprotein IIb/IIIa on plateletsB Bednar, M E Cunningham, P A McQueney, et al.
Blood|July 9, 1999
Fibrinogen receptor antagonist-induced thrombocytopenia in chimpanzee and rhesus monkey associated with preexisting drug-dependent antibodies to platelet glycoprotein IIb/IIIaB Bednar, J J Cook, M A Holahan, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 17, 1998
Identification of low molecular weight GP IIb/IIIa antagonists that bind preferentially to activated plateletsR A Bednar, S L Gaul, T G Hamill, et al.
Circulation|June 15, 1995
An antibody against the exosite of the cloned thrombin receptor inhibits experimental arterial thrombosis in the African green monkeyJ J Cook, G R Sitko, B Bednar, et al.
Bioorganic & Medicinal Chemistry Letters|September 15, 2000
Nonpeptide GPIIB/IIIA receptor antagonists. Part 21: C-6 flexibility and amide bond orientation are important factors in determining the affinity of compounds for activated or resting platelet receptorsM S Egbertson, B Bednar, B C Askew, et al.
Journal of Medicinal Chemistry|July 8, 1999
Non-peptide GPIIb/IIIa inhibitors. 20. Centrally constrained thienothiophene alpha-sulfonamides are potent, long acting in vivo inhibitors of platelet aggregationM S Egbertson, J J Cook, B Bednar, et al.
Pageof 3